Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
Avatar

Beyond "The Big Three" Lynch Syndrome-Linked Cancers: What Are the Risk Factors? Should We Screen for the "Other" Cancers?

By Dana-Farber Cancer Institute FEATURING Matthew Yurgelun
By Dana-Farber Cancer Institute FEATURING Matthew Yurgelun
6 views
January 28, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Gastrointestinal
35:41
Dana-Farber Cancer Institute

Prevention of Esophageal Cancer: Screening and Surveillance

Feat. K. Jajoo
13:51
Dana-Farber Cancer Institute

Overview of Dosing and Toxicity of Radiation Therapy in CRC

Feat. M. Lam
07:57
Dana-Farber Cancer Institute

Colorectal Cancer Treatment: A Surgical Perspective

Feat. J. Irani
19:34
Dana-Farber Cancer Institute

Symptoms and Side Effects of CRC Treatment

Feat. A. Enzinger
30:28
Dana-Farber Cancer Institute

Progress in Colorectal Cancer Treatment With Case Examples

Feat. D. Schrag
41:38
Dana-Farber Cancer Institute

Let Me Eat: The Road to Reconstructing the Esophagus

Feat. J. Wee
14:54
Oncology Data Advisor

Appendiceal Cancer Treatment Overview

Feat. T. Abrams
46:05
Dana-Farber Cancer Institute

Digesting the Science: An Informational Series on IO for Esophageal …

Feat. P. Enzinger
25:49
Dana-Farber Cancer Institute

Beyond "The Big Three" Lynch Syndrome-Linked Cancers: What…

Feat. M. Yurgelun
22:58
Dana-Farber Cancer Institute

Identification and Management of Toxicities Related to Immunotherapy…

Feat. O. Rahma